Main Article Content
Immunological markers (CD4 count) are used in developing countries to decide on initiation of antiretroviral therapy and monitor HIV/AIDS disease progression. HIV is an incurable chronic illness, making quality of life paramount. The direct relationship between quality of life and CD4 count is unclear. The purpose of this study is to determine the relationship between CD4 count clinical staging and quality of life of people living with HIV. The objectives of the study were. To correlate the QOL and CD4 cell count among HIV positive patients attending VCTC, To associate between the QOL and CD4 cell count of HIV positive patients and selected back ground variables. The methodology of the study A Quantitative descriptive study design was adopted and selected 60HIV positive patients by using convenient sampling technique on those who are attending VCTC (voluntary counselling and testing center) in Govt. District Hospital Vizianagaram.The researcher used an interview schedule to collect demographic and clinical data and modified the WHO QOL HIV BREF SCALE to assess the Quality of Life of HIV-positive patients from May 2017 to July 2017. CD4 count was identified using Cyflowmetry and Clinical staging of HIV infection was assessed using the checklist. The data were analysed by using descriptive and inferential statistics. The study concluded that there was a strong relationship between quality of life, CD4 count, and the clinical staging of HIV-positive patients. The CD4 cell count can help health care provider to plan appropriate treatment and plan of care.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.